Paul A. Wabnitz

757 total citations
24 papers, 610 citations indexed

About

Paul A. Wabnitz is a scholar working on Molecular Biology, Microbiology and Global and Planetary Change. According to data from OpenAlex, Paul A. Wabnitz has authored 24 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 13 papers in Microbiology and 8 papers in Global and Planetary Change. Recurrent topics in Paul A. Wabnitz's work include Antimicrobial Peptides and Activities (13 papers), Amphibian and Reptile Biology (8 papers) and Biochemical and Structural Characterization (8 papers). Paul A. Wabnitz is often cited by papers focused on Antimicrobial Peptides and Activities (13 papers), Amphibian and Reptile Biology (8 papers) and Biochemical and Structural Characterization (8 papers). Paul A. Wabnitz collaborates with scholars based in Australia, United States and South Korea. Paul A. Wabnitz's co-authors include John H. Bowie, Michael J. Tyler, John C. Wallace, Ben Smith, Kate L. Wegener, John A. Carver, Craig S. Brinkworth, Joseph A. Loo, Brian C. S. Chia and Jason Doyle and has published in prestigious journals such as Nature, Annals of Oncology and European Journal of Biochemistry.

In The Last Decade

Paul A. Wabnitz

23 papers receiving 599 citations

Peers

Countries citing papers authored by Paul A. Wabnitz

Since Specialization

Citations

This map shows the geographic impact of Paul A. Wabnitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul A. Wabnitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul A. Wabnitz more than expected).

Fields of papers citing papers by Paul A. Wabnitz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul A. Wabnitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul A. Wabnitz. The network helps show where Paul A. Wabnitz may publish in the future.

Co-authorship network of co-authors of Paul A. Wabnitz

This figure shows the co-authorship network connecting the top 25 collaborators of Paul A. Wabnitz. A scholar is included among the top collaborators of Paul A. Wabnitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul A. Wabnitz. Paul A. Wabnitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	First‐in‐human study of a pharmacological duodenal exclusion therapy shows reduced postprandial glucose and insulin and increased bile acid and gut hormone concentrations 2023 ·Diabetes Obesity and Metabolism ·Mark Fineman, (unknown), (unknown), (unknown), (unknown), Michael Horowitz, Jiten Vora, Christopher K. Rayner, Paul A. Wabnitz, Ashish Nimgaonkar	9
2	1047P AXA-042, a systemically administered TLR2/6 agonist, demonstrates target engagement and TLR pathway activation in patients with advanced solid tumors 2023 ·Annals of Oncology ·Ben Tran, Michael Millward, Charlotte Lemech, Sophia Frentzas, Daphne Day, Ali Mohammad Latifi, Jayesh Desai, Paul A. Wabnitz, Phil Kearney, Anna Galkin	0
3	Pharmacokinetic equivalence of CT‐P39 and reference omalizumab in healthy individuals: A randomised, double‐blind, parallel‐group, Phase 1 trial 2022 ·Clinical and Translational Allergy ·Marcus Maurer, Sarbjit S. Saini, (unknown), Paul A. Wabnitz, (unknown), (unknown), Su‐Young Kim, Sewon Lee, Clive Grattan	9
4	An immunomodulator used to protect young in the pouch of the Tammar wallaby, Macropus eugenii 2005 ·FEBS Journal ·R. V. Baudinette, Pinmanee Boontheung, Ian Musgrave, Paul A. Wabnitz, Vita M. Maselli, (unknown), Paul F. Alewood, Craig S. Brinkworth, John H. Bowie	16
5	In Vitro and in Vivo Metabolism of the Anti-Cancer Agent CI-1040, a MEK Inhibitor, in Rat, Monkey, and Human 2004 ·Pharmaceutical Research ·Paul A. Wabnitz, David Mitchell, David Wabnitz	17
6	nNOS inhibition, antimicrobial and anticancer activity of the amphibian skin peptide, citropin 1.1 and synthetic modifications 2003 ·European Journal of Biochemistry ·Jason Doyle, Craig S. Brinkworth, Kate L. Wegener, John A. Carver, Lyndon Llewellyn, Ian Olver, John H. Bowie, Paul A. Wabnitz, Michael J. Tyler	71
7	Amphibian peptides that inhibit neuronal nitric oxide synthase 2002 ·European Journal of Biochemistry ·Jason Doyle, Lyndon Llewellyn, Craig S. Brinkworth, John H. Bowie, Kate L. Wegener, Tomas Rozek, Paul A. Wabnitz, John C. Wallace, Michael J. Tyler	45
8	Negative ion electrospray mass spectra of caerulein peptides: an aid to structural determination 2002 ·Rapid Communications in Mass Spectrometry ·Pinmanee Boontheung, Paul F. Alewood, Craig S. Brinkworth, John H. Bowie, Paul A. Wabnitz, Michael J. Tyler	22
9	Drug screening of pharmaceutical discovery compounds by micro‐size exclusion chromatography/mass spectrometry 2001 ·Rapid Communications in Mass Spectrometry ·Paul A. Wabnitz, Joseph A. Loo	29
10	Differences in the skin peptides of the male and female Australian tree frog Litoria splendida 2000 ·European Journal of Biochemistry ·Paul A. Wabnitz, John H. Bowie, Michael J. Tyler, John C. Wallace, Ben Smith	58
11	Peptides from the Skin Glands of the Australian Buzzing Tree Frog Litoria electrica . Comparison with the Skin Peptides of the Red Tree Frog Litoria rubella 1999 ·Australian Journal of Chemistry ·Paul A. Wabnitz, John H. Bowie, John C. Wallace, Michael J. Tyler	21
12	The citropin peptides from the skin glands of the Australian Blue Mountains tree frog Litoria citropa. Part 2: Sequence determination using electrospray mass spectrometry 1999 ·Rapid Communications in Mass Spectrometry ·Paul A. Wabnitz, John H. Bowie, John C. Wallace, Michael J. Tyler	22
13	Host defence peptides from the skin glands of the Australian Blue Mountains tree‐frog Litoria citropa 1999 ·European Journal of Biochemistry ·Kate L. Wegener, Paul A. Wabnitz, John A. Carver, John H. Bowie, Brian C. S. Chia, John C. Wallace, Michael J. Tyler	73
14	Aquatic sex pheromone from a male tree frog 1999 ·Nature ·Paul A. Wabnitz, John H. Bowie, Michael J. Tyler, John C. Wallace, Ben Smith	98
15	Host Defence Antibacterial Peptides from Skin Secretions of Australian Amphibians. The Relationship Between Structure and Activity 1999 ·Protein and Peptide Letters ·John H. Bowie, Kate L. Wegener, Brian C. S. Chia, Paul A. Wabnitz, John A. Carver, Michael J. Tyler, John C. Wallace	32
16	Caerulein-like peptides from the skin glands of the Australian Blue Mountains tree frogLitoria citropa. Part 1. Sequence determination using electrospray mass spectrometry 1999 ·Rapid Communications in Mass Spectrometry ·Paul A. Wabnitz, John H. Bowie, Michael J. Tyler	33
17	First record of host defence peptides in tadpoles. The magnificent tree frog Litoria splendida 1998 ·Journal of Peptide Research ·Paul A. Wabnitz, (unknown), (unknown), John C. Wallace, John H. Bowie	20
18	New caerin 1 antibiotic peptides from the skin secretion of the Australian tree frogLitoria chloris. Part 2. Sequence determination using electrospray mass spectrometry 1998 ·Rapid Communications in Mass Spectrometry ·Paul A. Wabnitz, Simon T. Steinborner, Graeme Currie, John H. Bowie, Michael J. Tyler	7
19	The Application of Mass Spectrometry to the Study of Evolutionary Trends in Amphibians 1996 ·Rapid Communications in Mass Spectrometry ·Simon T. Steinborner, Paul A. Wabnitz, John H. Bowie, Michael J. Tyler	11
20	The negative ion mass spectra of deprotonated 2,5-diketopiperazines 1996 ·International Journal of Mass Spectrometry and Ion Processes ·Paul A. Wabnitz, Russell J. Waugh, (unknown), Suresh Dua, Thomas Blumenthal, John H. Bowie	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact